Anyone can suffer from pulmonary fibrosis, but it’s more common among middle-aged and older adults. Each patient has an individualized experience with the disease, which means that it can progress faster in some patients than others. As the lung tissue becomes thicker, the lungs lose their ability to properly…
Hyaluronan synthase 2 (HAS2) deletion from fibrotic fibroblasts induces senescence (gradual deterioration) in the cells and fibrotic clearance in mouse models of lung fibrosis. The findings, reported in the study “Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis” and published in the journal Matrix Biology, suggest…
According to the Pulmonary Fibrosis Foundation, there are some questions you should always keep in mind to ask your health care provider, to help you understand more about your disease and how it will affect your daily life. The most important thing is that you…
Nintedanib (marketed as OFEV by Boehringer Ingelheim) has shown very good results in clinical trials in patients with idiopathic pulmonary fibrosis (IPF). Nevertheless, some patients still experience disease exacerbation when treated with the drug. A case study described the successful reinstallation of the drug after an exacerbation — raising hopes…
In this video from ManagingSOB, it is discussed how to strengthen the respiratory muscles with respiratory muscle exercises. Learn more about pulmonary fibrosis: http://bit.ly/1VElTQA Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis…
Galectin Therapeutics, Inc., announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application “Method for Treatment of Pulmonary Fibrosis” — number 13/999,389 — on its lead compound GR-MD-02. Galectin Therapeutics is currently developing carbohydrate-based therapies…
There is currently no cure for pulmonary fibrosis and patients often face a prognosis of three to five years after diagnosis. However, medication and other treatment options can help improve patients’ quality of life. Medication for the treatment of patient with pulmonary fibrosis Nintedanib…
Men have higher rates of pulmonary fibrosis than women and tend to have a poorer survival. A study showed that mice exposed to silica, a known lung fibrosis trigger, have some sex-specific differences in their expression of the fibrotic factor SPP1, indicating that female sex hormones might alter molecular characteristics…
In this video from Elearnin, learn more about human lungs and how the different parts of respiratory system work. Learn more about pulmonary fibrosis: http://bit.ly/1VElTQA …
In 2012, alungstory’s channel posted this video on her youtube channel, trying to reach the comedian and TV presenter, Ellen DeGeneres. Hélène Campbell is a young girl who, at the time of the video, was waiting on a transplant list to get the double…
Get regular updates to your inbox.
